Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Applying to University of Chicago Medicine-Orland Park · Orland Park, Illinois
Answer a few short questions to share with the research team.